Clinical Trial Update: The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating ramipril's effect on suppressing ST2 expression in patients with rheumatic mitral stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Stenosis
• Rheumatic Heart Disease
• Rheumatic Mitral Stenosis

Drugs mentioned

• Ramipril (ramipril)

Snippet

Sponsor: Indonesia University | Conditions: Rheumatic Heart Disease, Mitral Stenosis | Phase 3 | Status: UNKNOWN